4552 (4552) News
Follow 4552 (4552) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 4 public stories across 2 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
L
Jcr Pharmaceuticals Receives Orphan Drug Designation For Givinostat In Japan
JCR Pharmaceuticals Co., Ltd. TSE:4552
NEWS | Sep 28, 2026, 05:11 PM UTC
L
JCR Pharmaceuticals Co., Ltd. Wins Japan Orphan, Priority Review for Givinostat in DMD
JCR Pharmaceuticals received orphan drug designation and Priority Examination in Japan for givinostat for Duchenne muscular dystrophy and plans to file for marketing approval by end-2026.Material DetailsContext by AI Ana
NEWS | Sep 28, 2026, 04:55 PM UTC
L
JCR Pharmaceuticals Receives Orphan Drug Designation from the Ministry of Health, Labour and Welfare of Japan for Givinostat for Duchenne Muscular Dystrophy
JCR Pharmaceuticals Co., Ltd. (TSE 4552; “JCR”) today announced that the Ministry of Health, Labour and Welfare of Japan granted orphan drug designation to givinostat, an investigational drug for the treatment of Duchenn
NEWS | Sep 28, 2026, 04:55 PM UTC
L
Lida Holdings reports 2Q net loss of NT$22.0M
Lida Holdings reported a 2Q net loss of NT$22.0M versus net profit of NT$24.6M.
EARNINGS | Aug 28, 2026, 10:44 AM UTC